Moderna’s next step will be a 30,000-participant Phase 3 study set to start July 27, which will include South Florida facilities.
Proposed COVID-19 Vaccine Becomes First in U.S. to Reach Phase 3 Test Trials
Veuer
A proposed coronavirus vaccine becomes the first in the U.S. to start phase three trials. Veuer’s Justin Kircher has the story.
